Epirus Biopharmaceuticals Files for Chapter 7 Bankruptcy - JD Supra ...

07/27/16

Epirus Biopharmaceuticals Files for Chapter 7 Bankruptcy
JD Supra (press release)
Epirus Biopharmaceuticals, a biosimilar startup, has filed for Chapter 7 bankruptcy. The Boston-based startup had lost approximately 82% of its value by June of 2016, after an announcement that it would cease working on a biosimilar of Remicade ...